Clinical Trial Update: Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria [Phase 4]

View source ↗

Summary

Phase 4 trial investigating atezolizumab and bevacizumab before liver transplantation in hepatocellular carcinoma patients beyond Milan criteria; currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Atezolizumab (atezolizumab)
• Bevacizumab (bevacizumab)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Hepatocellular Carcinoma, Hepatocellular Cancer | Phase 4 | Status: RECRUITING